Tropical Weather Alert: For the latest updates on closures or modified hours for our UF Health clinical facilities, click here
Clinical trials
-
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma (RADICAL) The addition of targeted immunotherapy will be safe and well tolerated and facilitate the reduction of anthracycline exposure while preserving lymphoma disease control in children, adolescents and young adults (CAYA) with mature B-cell non-Hodgkin…
- Investigator
- William Slayton
- Ages
- 3 Years - 39 Years
- Sexes
- All
-
PBTC-060 Patients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells…
- Investigators
- Elias Sayour, Jennifer F King
- Ages
- 1 Year - 21 Years
- Sexes
- All